InVivo: InVivo Therapeutics' creditors approve Chapter 11 bankruptcy liquidation plan
InVivo Therapeutics' creditors voted to approve the company's Chapter 11 liquidation plan, according to a June 17 declaration filed in the U.S. Bankruptcy Court for the District of Delaware.
Read full article »
InVivo is a Massachusetts-based biotechnology company that develops neurological products for the treatment of spinal cord injuries.
Read more